908 Devices (NASDAQ: MASS) — Company Overview, News & Financial Data
908 Devices creates portable mass spectrometry devices for life sciences and industrial applications to enhance diagnostics.
908 Devices
908 Devices (NASDAQ:MASS) is a company deeply involved in creating robust mass spectrometry devices that cater to the needs of life sciences research, biopharmaceuticals, and industrial applications. Their mission revolves around democratizing the use of advanced mass spectrometry tools by developing portable, handheld devices. 908 Devices is committed to pushing the boundaries of chemical analysis and diagnostics, aiming to make these technologies more accessible and user-friendly. Whether it's enhancing drug development processes, improving clinical diagnostics, or ensuring safety in industrial environments, their projects are designed to have a significant impact across various fields. The company is dedicated to ongoing innovation, aiming to expand its product line and enhance the capabilities of existing devices to meet the evolving needs of their customers.
Snapshot
Operations
Products and/or services of 908 Devices
- MX908 is a handheld chemical detection tool designed for hazardous substances and priority drugs, including fentanyl and synthetic opioids.
- REBEL is a compact, desktop system for analyzing cell culture media and fermentation, aiding bioprocess monitoring and optimization.
- ZipChip is an integrated electrophoresis system that prepares, separates, and analyzes biological samples, streamlining workflows for biopharmaceutical development.
- G908 is a portable mass spectrometer combining high-pressure mass spectrometry with ballistic chemical analysis, aimed at environmental monitoring and food safety testing.
- M908 is an earlier, lightweight, handheld device for chemical detection and identification, serving emergency responders and military personnel.
- Guardion is a rugged, portable gas chromatograph-mass spectrometer (GC-MS) system for on-site chemical identification, tailored to defense and security applications.
908 Devices executive team
- Kevin J. KnoppCo-Founder, CEO, President & Director
- Christopher David BrownCo-Founder, Board Advisor & Director
- Joseph H. Griffith IVCFO & Treasurer
- Mark S. LevineChief Legal, Administrative Officer & Corporate Secretary
- John KennewegSenior Vice President of Sales and Product Marketing
- Julie CincottiGlobal Head of Human Resources
- Kevin McCallionSenior Vice President of Products and Production
- Kola OtitojuChief Business & Strategy Officer
Key financials
Reported results for 908 Devices, in USD.
- Market cap
- 465M
- Revenue (TTM)
- 60.8M
- P/E ratio
- —
- EPS (diluted, TTM)
- -0.9
- Dividend yield
- —
- Profit margin
- -57.0%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 56.2M | -24.2M | -36.6M | |
| 59.6M | -76.7M | -72.2M | |
| 50.2M | -42.8M | -36.4M | |
| 46.9M | -35.4M | -31.7M |